Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial

Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial

30 Aug 2021 1:08 PM | Michele O'Bright (Administrator)

Karyn A. Goodman; Fang-Shu Ou; Nathan C. Hall; Tanios Bekaii-Saab; Briant Fruth; Erin Twohy; Michael O. Meyers; Daniel J. Boffa; Kisha Mitchell; Wendy L. Frankel; Donna Niedzwiecki; Anne Noonan; Yelena Y. Janjigian; Paul J. Thurmes; Alan P. Venook; Jeffrey A. Meyerhardt; Eileen M. O'Reilly; and David H. Ilson

Read the full abstract...

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software